This white paper provides practical strategies for easing the participation burden and introduces considerations for selecting technology that can seamlessly integrate clinical trials into patients’ lives.
PRA Talks COVID-19 Impact on Rare Disease Clinical Trials with Patient Advocates
PRA’s Center for Rare Diseases understands that clinical trials are both a source of hope and care for people affected by a rare disease. The impact…
Benefits of Cross-Border Enrollment
Rare Disease Newsletter
This quarterly publication will keep you informed about key news in the world of rare disease clinical research and update you on what the PRA Health…